600380 健康元
交易中 08-13 09:50:41
资讯
新帖
简况
每周股票复盘：健康元（600380）为子公司新增担保8.62亿元
证券之星 · 08-09
每周股票复盘：健康元（600380）为子公司新增担保8.62亿元
健康元获得外观设计专利授权：“包装套件（太太桃红饮礼盒套装）”
证券之星 · 08-07
健康元获得外观设计专利授权：“包装套件（太太桃红饮礼盒套装）”
股市必读：健康元新发布《健康元药业集团股份有限公司关于为控股子公司提供担保进展情况的公告》
证券之星 · 08-06
股市必读：健康元新发布《健康元药业集团股份有限公司关于为控股子公司提供担保进展情况的公告》
健康元（600380）披露为控股子公司提供担保进展情况，8月4日股价下跌0.68%
证券之星 · 08-04
健康元（600380）披露为控股子公司提供担保进展情况，8月4日股价下跌0.68%
股市必读：健康元新发布《健康元药业集团股份有限公司关于向控股子公司焦作健风提供委托贷款的进展公告》
证券之星 · 08-03
股市必读：健康元新发布《健康元药业集团股份有限公司关于向控股子公司焦作健风提供委托贷款的进展公告》
每周股票复盘：健康元（600380）壹立康上市推进、持股计划延期
证券之星 · 08-02
每周股票复盘：健康元（600380）壹立康上市推进、持股计划延期
243万股“深套”？健康元中长期事业合伙人持股计划再度延期！
市场资讯 · 07-29
243万股“深套”？健康元中长期事业合伙人持股计划再度延期！
健康元（600380）披露第一期中长期事业合伙人持股计划延长存续期公告，7月27日股价上涨1.19%
证券之星 · 07-27
健康元（600380）披露第一期中长期事业合伙人持股计划延长存续期公告，7月27日股价上涨1.19%
健康元：7月24日接受机构调研，泰康资产、浙商医药参与
证券之星 · 07-27
健康元：7月24日接受机构调研，泰康资产、浙商医药参与
每周股票复盘：健康元（600380）获中药3.1类新药注册证书
证券之星 · 07-26
每周股票复盘：健康元（600380）获中药3.1类新药注册证书
健康元（600380）披露获得《药品注册证书》公告，7月23日股价下跌1.62%
证券之星 · 07-23
健康元（600380）披露获得《药品注册证书》公告，7月23日股价下跌1.62%
健康元最新公告：子公司获半夏白术天麻汤颗粒药品注册证书
证券之星 · 07-23
健康元最新公告：子公司获半夏白术天麻汤颗粒药品注册证书
每周股票复盘：健康元（600380）拟每股派现0.22元
证券之星 · 06-20
每周股票复盘：健康元（600380）拟每股派现0.22元
健康元（600380）披露2025年年度权益分派实施公告，6月17日股价下跌1.31%
证券之星 · 06-17
健康元（600380）披露2025年年度权益分派实施公告，6月17日股价下跌1.31%
每周股票复盘：健康元（600380）重组人促卵泡激素获批
证券之星 · 06-07
每周股票复盘：健康元（600380）重组人促卵泡激素获批
健康元（600380）披露2025年年度股东会决议公告，6月1日股价上涨0.39%
证券之星 · 06-01
健康元（600380）披露2025年年度股东会决议公告，6月1日股价上涨0.39%
健康元最新公告：莱康奇塔单抗注射液上市许可申请获受理
证券之星 · 06-01
健康元最新公告：莱康奇塔单抗注射液上市许可申请获受理
健康元最新公告：子公司丽珠单抗获重组人促卵泡激素注射液药品注册证书
证券之星 · 06-01
健康元最新公告：子公司丽珠单抗获重组人促卵泡激素注射液药品注册证书
健康元（600380）披露2025年年度股东会召开提示性公告，5月25日股价下跌0.69%
证券之星 · 05-25
健康元（600380）披露2025年年度股东会召开提示性公告，5月25日股价下跌0.69%
每周股票复盘：健康元（600380）将召开2025年年度股东会
证券之星 · 05-24
每周股票复盘：健康元（600380）将召开2025年年度股东会
公司概况
公司名称：
健康元药业集团股份有限公司
所属行业：
医药制造业
上市日期：
2001-06-08
主营业务：
健康元药业集团股份有限公司的主营业务是医药产品及保健品研发、生产及销售。公司的主要产品是化学制剂、化学原料药及中间体、中药制剂、诊断试剂及设备、保健食品、生物制品。
发行价格：
24.80
{"stockData":{"symbol":"600380","market":"SH","secType":"STK","nameCN":"健康元","latestPrice":10.31,"timestamp":1786585841000,"preClose":10.32,"halted":0,"volume":4848900,"delay":0,"changeRate":-0.001,"floatShares":1829000000,"shares":1829000000,"eps":0.7187,"marketStatus":"交易中","change":-0.01,"latestTime":"08-13 09:50:41","open":10.32,"high":10.33,"low":10.16,"amount":49627400,"amplitude":0.0165,"askPrice":10.32,"askSize":6,"bidPrice":10.31,"bidSize":113,"shortable":0,"etf":0,"ttmEps":0.7187,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1786591800000},"marketStatusCode":2,"adr":0,"adjPreClose":10.32,"symbolType":"stock","openAndCloseTimeList":[[1786584600000,1786591800000],[1786597200000,1786604400000]],"highLimit":11.35,"lowLimit":9.29,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1829453386,"isCdr":false,"pbRate":1.21,"roa":"--","peRate":14.345346,"roe":"2.7%","epsLYR":0.73,"committee":-0.419182,"marketValue":18862000000,"turnoverRate":0.0027,"status":1,"floatMarketCap":18862000000},"requestUrl":"/m/hq/s/600380/wiki","defaultTab":"wiki","newsList":[{"id":"2658003673","title":"每周股票复盘：健康元（600380）为子公司新增担保8.62亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2658003673","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658003673?lang=zh_cn&edition=full","pubTime":"2026-08-09 02:18","pubTimestamp":1786213092,"startTime":"0","endTime":"0","summary":"截至2026年8月7日收盘，健康元报收于10.26元，较上周的10.25元上涨0.1%。本周，健康元8月4日盘中最高价报10.37元。健康元当前最新总市值187.7亿元，在化学制药板块市值排名23/149，在两市A股市值排名1047/5205。本周关注点公司公告汇总：健康元为控股子公司新增担保86,200万元。截至2026年7月31日，公司及其控股子公司对外担保余额为206,875.16万元，占最近一期经审计净资产的13.63%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080900000615.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0046","BK0077","BK0239","600380","BK0028","BK0114"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657654718","title":"健康元获得外观设计专利授权：“包装套件（太太桃红饮礼盒套装）”","url":"https://stock-news.laohu8.com/highlight/detail?id=2657654718","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657654718?lang=zh_cn&edition=full","pubTime":"2026-08-07 03:26","pubTimestamp":1786044379,"startTime":"0","endTime":"0","summary":"证券之星消息，根据天眼查APP数据显示健康元新获得一项外观设计专利授权，专利名为“包装套件”，专利申请号为CN202530728761.8，授权日为2026年8月7日。今年以来健康元新获得专利授权6个，较去年同期减少了14.29%。通过天眼查大数据分析，健康元药业集团股份有限公司共对外投资了27家企业，参与招投标项目204次；财产线索方面有商标信息1430条，专利信息168条，著作权信息31条；此外企业还拥有行政许可116个。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080700004162.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","600380","BK0114","BK0239","BK0028","BK0188","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657524679","title":"股市必读：健康元新发布《健康元药业集团股份有限公司关于为控股子公司提供担保进展情况的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2657524679","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657524679?lang=zh_cn&edition=full","pubTime":"2026-08-06 02:15","pubTimestamp":1785953713,"startTime":"0","endTime":"0","summary":"公司公告汇总：健康元于2026年7月为多家控股子公司新增担保86,200万元，均在前期预计额度内；截至7月31日，对外担保余额206,875.16万元，占最近一期经审计净资产的13.63%。公司公告汇总健康元药业集团股份有限公司关于为控股子公司提供担保进展情况的公告健康元药业集团股份有限公司于2026年7月为多家控股子公司提供担保，合计新增担保金额86,200万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080600001868.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","BK0077","BK0239","600380","BK0188","BK0046","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656055212","title":"健康元（600380）披露为控股子公司提供担保进展情况，8月4日股价下跌0.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2656055212","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656055212?lang=zh_cn&edition=full","pubTime":"2026-08-04 22:25","pubTimestamp":1785853519,"startTime":"0","endTime":"0","summary":"截至2026年8月4日收盘，健康元报收于10.19元，较前一交易日下跌0.68%，最新总市值为186.42亿元。该股当日开盘10.28元，最高10.37元，最低10.18元，成交额达1.6亿元，换手率为0.85%。近日，健康元药业集团股份有限公司发布《关于为控股子公司提供担保进展情况的公告》。公告显示，公司于2026年7月为多家控股子公司提供担保，合计新增担保金额86,200万元。截至2026年7月31日，公司及其控股子公司对外担保余额为206,875.16万元，占最近一期经审计净资产的13.63%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080400041511.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0239","600380","BK0114","BK0028","BK0046","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656343944","title":"股市必读：健康元新发布《健康元药业集团股份有限公司关于向控股子公司焦作健风提供委托贷款的进展公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2656343944","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656343944?lang=zh_cn&edition=full","pubTime":"2026-08-03 03:03","pubTimestamp":1785697394,"startTime":"0","endTime":"0","summary":"公司公告汇总健康元药业集团股份有限公司关于向控股子公司焦作健风提供委托贷款的进展公告健康元于2026年7月28日与招商银行深圳分行、控股子公司焦作健风签署《委托贷款借款合同》，提供委托贷款3,000万元，期限五年，年利率3.00%，按一年期LPR执行，每年调整一次；利息按月支付，本金到期一次性归还。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080300001208.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0239","BK0028","BK0114","BK0077","600380","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656319559","title":"每周股票复盘：健康元（600380）壹立康上市推进、持股计划延期","url":"https://stock-news.laohu8.com/highlight/detail?id=2656319559","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656319559?lang=zh_cn&edition=full","pubTime":"2026-08-02 03:06","pubTimestamp":1785611174,"startTime":"0","endTime":"0","summary":"截至2026年7月31日收盘，健康元报收于10.25元，较上周的10.05元上涨1.99%。本周，健康元7月30日盘中最高价报10.35元。健康元药业集团股份有限公司第一期持股计划第三次持有人会议于2026年7月27日以通讯方式召开，出席会议持有人27人，代表份额19,106,245份，占总份额的61.56%。表决结果为同意占比100%，无反对或弃权。健康元药业集团股份有限公司于2026年7月27日召开九届董事会二十次会议，审议通过《关于第一期中长期事业合伙人持股计划延长存续期的议案》，","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080200000940.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","600380","BK0114","BK0239","BK0028","BK0188","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655361108","title":"243万股“深套”？健康元中长期事业合伙人持股计划再度延期！","url":"https://stock-news.laohu8.com/highlight/detail?id=2655361108","media":"市场资讯","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655361108?lang=zh_cn&edition=full","pubTime":"2026-07-29 06:46","pubTimestamp":1785278760,"startTime":"0","endTime":"0","summary":"来源：深圳商报","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-07-29/doc-inikmivt1685793.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0028","BK0188","BK0046","BK0239","600380","BK0114","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654046325","title":"健康元（600380）披露第一期中长期事业合伙人持股计划延长存续期公告，7月27日股价上涨1.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2654046325","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654046325?lang=zh_cn&edition=full","pubTime":"2026-07-27 22:27","pubTimestamp":1785162436,"startTime":"0","endTime":"0","summary":"截至2026年7月27日收盘，健康元报收于10.17元，较前一交易日上涨1.19%，最新总市值为186.06亿元。近日，健康元药业集团股份有限公司发布《关于第一期中长期事业合伙人持股计划延长存续期的公告》。公告显示，公司于2026年7月27日召开九届董事会二十次会议，审议通过《关于第一期中长期事业合伙人持股计划延长存续期的议案》，同意将第一期持股计划存续期延长12个月至2027年8月3日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072700034976.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0239","BK0077","BK0114","600380","BK0028","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654501690","title":"健康元：7月24日接受机构调研，泰康资产、浙商医药参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2654501690","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654501690?lang=zh_cn&edition=full","pubTime":"2026-07-27 17:41","pubTimestamp":1785145303,"startTime":"0","endTime":"0","summary":"证券之星消息，2026年7月27日健康元发布公告称公司于2026年7月24日接受机构调研，泰康资产翟雪、浙商医药郭双喜参与。健康元目前已经形成了较为均衡、多元的收入结构，更重要的是，公司正持续以创新驱动收入结构升级。2025 年公司保健食品板块收入同比增长约 37%，进入 2026 年后，在较高基数基础上仍保持良好增长态势，其中鹰牌等核心品牌表现较为突出。健康元主营业务：医药产品及保健品研发、生产及销售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072700023259.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09939","BK0077","BK1161","BK0028","159938","BK0188","BK0239","600380","BK1515","BK1574","BK0114","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654575320","title":"每周股票复盘：健康元（600380）获中药3.1类新药注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2654575320","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654575320?lang=zh_cn&edition=full","pubTime":"2026-07-26 02:18","pubTimestamp":1785003494,"startTime":"0","endTime":"0","summary":"截至2026年7月24日收盘，健康元报收于10.05元，较上周的10.26元下跌2.05%。本周关注点公司公告汇总：健康元控股子公司获半夏白术天麻汤颗粒《药品注册证书》，为公司首款中药3.1类新药。公司公告汇总健康元药业集团股份有限公司控股子公司四川光大制药有限公司收到国家药品监督管理局签发的《药品注册证书》，其申报的半夏白术天麻汤颗粒符合药品注册要求，批准上市。该药品为公司首款获批上市的中药3.1类新药，将进一步丰富产品管线。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072600000635.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0077","BK0114","BK0239","600380","BK0046","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653409726","title":"健康元（600380）披露获得《药品注册证书》公告，7月23日股价下跌1.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2653409726","media":"证券之星","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653409726?lang=zh_cn&edition=full","pubTime":"2026-07-23 22:20","pubTimestamp":1784816430,"startTime":"0","endTime":"0","summary":"截至2026年7月23日收盘，健康元报收于10.31元，较前一交易日下跌1.62%，最新总市值为188.62亿元。该股当日开盘10.45元，最高10.48元，最低10.16元，成交额达1.73亿元，换手率为0.92%。近日，健康元药业集团股份有限公司发布关于获得《药品注册证书》的公告。公告显示，公司控股子公司四川光大制药有限公司收到国家药品监督管理局签发的《药品注册证书》，其申报的半夏白术天麻汤颗粒符合药品注册要求，批准上市。截至公告日，累计研发投入约501.02万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072300048030.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0077","600380","BK0114","BK0188","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653749165","title":"健康元最新公告：子公司获半夏白术天麻汤颗粒药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2653749165","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653749165?lang=zh_cn&edition=full","pubTime":"2026-07-23 18:30","pubTimestamp":1784802647,"startTime":"0","endTime":"0","summary":"健康元(600380.SH)公告称，公司控股子公司丽珠集团的子公司四川光大制药有限公司收到国家药品监督管理局签发的《药品注册证书》，批准半夏白术天麻汤颗粒上市。该药品为中药3.1类新药，是公司首款获批的中药3.1类新药，将进一步丰富公司产品管线。截至公告日，该药品累计研发投入约501.02万元。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072300038154.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0114","BK0188","BK0046","600380","BK0239","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644630150","title":"每周股票复盘：健康元（600380）拟每股派现0.22元","url":"https://stock-news.laohu8.com/highlight/detail?id=2644630150","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2644630150?lang=zh_cn&edition=full","pubTime":"2026-06-20 02:36","pubTimestamp":1781894173,"startTime":"0","endTime":"0","summary":"截至2026年6月18日收盘，健康元报收于9.81元，较上周的10.04元下跌2.29%。本周，健康元6月16日盘中最高价报10.15元。本周关注点公司公告汇总：健康元拟每股派发现金红利0.22元（含税），股权登记日为2026年6月25日。公司公告汇总健康元药业集团股份有限公司发布2025年年度权益分派实施公告，每股派发现金红利0.22元（含税），以公司总股本1,829,453,386股为基数，合计派发现金红利402,479,744.92元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062000000781.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","600380","BK0188","BK0114","BK0077","BK0046","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644651742","title":"健康元（600380）披露2025年年度权益分派实施公告，6月17日股价下跌1.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2644651742","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2644651742?lang=zh_cn&edition=full","pubTime":"2026-06-17 22:40","pubTimestamp":1781707222,"startTime":"0","endTime":"0","summary":"截至2026年6月17日收盘，健康元报收于9.78元，较前一交易日下跌1.31%，最新总市值为178.92亿元。该股当日开盘9.87元，最高9.93元，最低9.74元，成交额达1.02亿元，换手率为0.57%。近日，健康元药业集团股份有限公司披露2025年年度权益分派实施公告，每股派发现金红利0.22元（含税），以公司总股本1,829,453,386股为基数，合计派发现金红利402,479,744.92元。股权登记日为2026年6月25日，除权（息）日和现金红利发放日均为2026年6月26日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061700042402.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","BK0028","BK0239","BK0188","BK0046","600380","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641220341","title":"每周股票复盘：健康元（600380）重组人促卵泡激素获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2641220341","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2641220341?lang=zh_cn&edition=full","pubTime":"2026-06-07 01:51","pubTimestamp":1780768271,"startTime":"0","endTime":"0","summary":"截至2026年6月5日收盘，健康元报收于9.91元，较上周的10.2元下跌2.84%。本周，健康元6月2日盘中最高价报10.29元。本期持股计划累计购入公司股票6,275,372股，占总股本0.34%，锁定期已届满，目前尚未完成全部股票出售。本次申请尚需经国家药监局审评审批，存在不确定性。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060700000445.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","BK0077","BK0239","BK0188","BK0046","600380","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640477950","title":"健康元（600380）披露2025年年度股东会决议公告，6月1日股价上涨0.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2640477950","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2640477950?lang=zh_cn&edition=full","pubTime":"2026-06-01 22:37","pubTimestamp":1780324632,"startTime":"0","endTime":"0","summary":"截至2026年6月1日收盘，健康元报收于10.24元，较前一交易日上涨0.39%，最新总市值为187.34亿元。该股当日开盘10.21元，最高10.28元，最低10.1元，成交额达1.29亿元，换手率为0.69%。健康元药业集团股份有限公司于2026年6月1日召开2025年年度股东会，审议通过了《2025年度董事会工作报告》《2025年度财务决算报告》《2025年度利润分配方案》等九项议案。会议采取现场与网络投票结合方式，表决结果均为通过，无否决议案。中小投资者对多项议案进行了单独计票。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060100041289.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600380","BK0046","BK0028","BK0077","BK0188","BK0114","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640554729","title":"健康元最新公告：莱康奇塔单抗注射液上市许可申请获受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2640554729","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2640554729?lang=zh_cn&edition=full","pubTime":"2026-06-01 19:01","pubTimestamp":1780311694,"startTime":"0","endTime":"0","summary":"健康元(600380.SH)公告称，公司控股子公司丽珠集团旗下丽珠单抗与北京鑫康合联合开发的莱康奇塔单抗注射液，用于治疗强直性脊柱炎的境内生产药品注册上市许可申请已获国家药监局受理。该药品为治疗用生物制品1类，规格为160mg/瓶，采用每4周皮下注射方案。截至公告日，该药品累计研发投入约2.17亿元。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060100033164.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","600380","BK0028","BK0114","BK0046","BK0188","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640955442","title":"健康元最新公告：子公司丽珠单抗获重组人促卵泡激素注射液药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2640955442","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2640955442?lang=zh_cn&edition=full","pubTime":"2026-06-01 19:00","pubTimestamp":1780311630,"startTime":"0","endTime":"0","summary":"健康元(600380.SH)公告称，公司控股子公司丽珠集团旗下丽珠单抗收到国家药监局核准签发的重组人促卵泡激素注射液《药品注册证书》。该药品适用于无排卵妇女、辅助生育技术中超排卵及严重缺乏促黄体激素和促卵泡激素的患者。截至公告日，该药品累计研发投入约1.22亿元。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060100033162.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","600380","BK0077","BK0114","BK0046","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638531279","title":"健康元（600380）披露2025年年度股东会召开提示性公告，5月25日股价下跌0.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2638531279","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2638531279?lang=zh_cn&edition=full","pubTime":"2026-05-25 17:49","pubTimestamp":1779702555,"startTime":"0","endTime":"0","summary":"截至2026年5月25日收盘，健康元报收于10.05元，较前一交易日下跌0.69%，最新总市值为183.86亿元。该股当日开盘10.11元，最高10.15元，最低9.97元，成交额达1.19亿元，换手率为0.65%。健康元药业集团股份有限公司于近日发布《关于召开2025年年度股东会的提示性公告》。公告显示，公司定于2026年6月1日召开2025年年度股东会，会议采取现场投票与网络投票相结合方式。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052500025283.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0188","BK0046","BK0239","600380","BK0114","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637137511","title":"每周股票复盘：健康元（600380）将召开2025年年度股东会","url":"https://stock-news.laohu8.com/highlight/detail?id=2637137511","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2637137511?lang=zh_cn&edition=full","pubTime":"2026-05-24 03:54","pubTimestamp":1779566053,"startTime":"0","endTime":"0","summary":"截至2026年5月22日收盘，健康元报收于10.12元，较上周的10.49元下跌3.53%。本周，健康元5月18日盘中最高价报10.48元。5月22日盘中最低价报10.08元，股价触及近一年最低点。健康元当前最新总市值185.14亿元，在化学制药板块市值排名27/150，在两市A股市值排名1196/5206。本周关注点公司公告汇总：健康元将于2026年6月1日召开2025年年度股东会。现场会议于14:00在深圳市南山区高新区北区朗山路17号健康元药业集团大厦二号会议室举行。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052400001168.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0239","BK0077","600380","BK0028","BK0188","BK0114"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1786585844440,"stockEarnings":[{"period":"1week","weight":0.0208},{"period":"1month","weight":0.0218},{"period":"3month","weight":-0.0107},{"period":"6month","weight":-0.0749},{"period":"1year","weight":-0.1391},{"period":"ytd","weight":-0.0862}],"compareEarnings":[{"period":"1week","weight":0.0176},{"period":"1month","weight":0.0084},{"period":"3month","weight":-0.0553},{"period":"6month","weight":-0.0332},{"period":"1year","weight":0.0766},{"period":"ytd","weight":-0.0056}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"健康元药业集团股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"76018人(较上一季度减少3.19%)","perCapita":"24066股","listingDate":"2001-06-08","address":"广东省深圳市南山区高新区北区朗山路17号健康元药业集团大厦","registeredCapital":"182945万元","survey":" 健康元药业集团股份有限公司的主营业务是医药产品及保健品研发、生产及销售。公司的主要产品是化学制剂、化学原料药及中间体、中药制剂、诊断试剂及设备、保健食品、生物制品。","listedPrice":24.8},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"健康元(600380)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供健康元(600380)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"健康元,600380,健康元股票,健康元股票老虎,健康元股票老虎国际,健康元行情,健康元股票行情,健康元股价,健康元股市,健康元股票价格,健康元股票交易,健康元股票购买,健康元股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"健康元(600380)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供健康元(600380)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}